18438916|t|Amyloid beta peptide toxicity in differentiated PC12 cells: calpain-calpastatin, caspase, and membrane damage.
18438916|a|Amyloid beta peptide (Abeta) is implicated in the pathogenesis of Alzheimer's disease (AD). The peptide is toxic to neurons, possibly by causing initial synaptic dysfunction and neuronal membrane dystrophy, promoted by increased cellular Ca(2+). Calpain (Ca(2+)-dependent protease) and caspase have also been implicated in AD. There is little information on communication between the two proteases or on the involvement of calpastatin (the specific calpain inhibitor) in Abeta toxicity. We studied the effects of Abeta25-35 (sAbeta) on calpain, calpastatin, and caspase in neuronal-like differentiated PC12 cells. sAbeta-treated cells exhibited primarily cell membrane damage (varicosities along neurites, enhanced membrane permeability to propidium iodide, without apparent nuclear changes of apoptosis, and little poly (ADP-ribose) polymerase [PARP] degradation). The sAbeta-induced membrane damage is in contrast with staurosporine-induced damage (nuclear apoptotic changes, PARP degradation, without membrane propidium iodide permeability). sAbeta led to activation of caspase-8 and calpain, promotion of calpastatin degradation (by caspase-8 and by calpain), and enhanced degradation of fodrin (mainly by calpain). The results support the idea that Abeta causes primarily neuronal membrane dysfunction, and point to cross-talk between calpain and caspase (protease activation and degradation of calpastatin) in Abeta toxicity. Increased expression of calpastatin and/or decrease in calpain and caspase-8 may serve as means for ameliorating early symptoms of AD.
18438916	21	29	toxicity	Disease	MESH:D064420
18438916	48	52	PC12	CellLine	CVCL:0481
18438916	68	79	calpastatin	Gene	25403
18438916	133	138	Abeta	Gene	54226
18438916	177	196	Alzheimer's disease	Disease	MESH:D000544
18438916	198	200	AD	Disease	MESH:D000544
18438916	264	284	synaptic dysfunction	Disease	MESH:C536122
18438916	289	316	neuronal membrane dystrophy	Disease	MESH:D015433
18438916	349	355	Ca(2+)	Chemical	-
18438916	434	436	AD	Disease	MESH:D000544
18438916	534	545	calpastatin	Gene	25403
18438916	582	587	Abeta	Gene	54226
18438916	588	596	toxicity	Disease	MESH:D064420
18438916	636	642	sAbeta	Gene	117186
18438916	656	667	calpastatin	Gene	25403
18438916	713	717	PC12	CellLine	CVCL:0481
18438916	725	731	sAbeta	Gene	117186
18438916	851	867	propidium iodide	Chemical	MESH:D011419
18438916	927	955	poly (ADP-ribose) polymerase	Gene	25591
18438916	981	987	sAbeta	Gene	117186
18438916	1032	1045	staurosporine	Chemical	MESH:D019311
18438916	1124	1140	propidium iodide	Chemical	MESH:D011419
18438916	1156	1162	sAbeta	Gene	117186
18438916	1184	1193	caspase-8	Gene	64044
18438916	1220	1231	calpastatin	Gene	25403
18438916	1248	1257	caspase-8	Gene	64044
18438916	1365	1370	Abeta	Gene	54226
18438916	1388	1417	neuronal membrane dysfunction	Disease	MESH:D015433
18438916	1511	1522	calpastatin	Gene	25403
18438916	1527	1532	Abeta	Gene	54226
18438916	1533	1541	toxicity	Disease	MESH:D064420
18438916	1567	1578	calpastatin	Gene	25403
18438916	1610	1619	caspase-8	Gene	64044
18438916	1674	1676	AD	Disease	MESH:D000544
18438916	Association	117186	25403
18438916	Positive_Correlation	MESH:D015433	54226
18438916	Association	25403	54226
18438916	Positive_Correlation	117186	64044
18438916	Association	MESH:D000544	64044
18438916	Association	MESH:D000544	54226
18438916	Association	25403	64044
18438916	Association	MESH:D011419	117186
18438916	Negative_Correlation	117186	25591
18438916	Association	MESH:D000544	25403

